These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31281901)

  • 61. An H3K36 methylation-engaging Tudor motif of polycomb-like proteins mediates PRC2 complex targeting.
    Cai L; Rothbart SB; Lu R; Xu B; Chen WY; Tripathy A; Rockowitz S; Zheng D; Patel DJ; Allis CD; Strahl BD; Song J; Wang GG
    Mol Cell; 2013 Feb; 49(3):571-82. PubMed ID: 23273982
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma.
    Lewis PW; Müller MM; Koletsky MS; Cordero F; Lin S; Banaszynski LA; Garcia BA; Muir TW; Becher OJ; Allis CD
    Science; 2013 May; 340(6134):857-61. PubMed ID: 23539183
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Polycomb-dependent H3K27me1 and H3K27me2 regulate active transcription and enhancer fidelity.
    Ferrari KJ; Scelfo A; Jammula S; Cuomo A; Barozzi I; Stützer A; Fischle W; Bonaldi T; Pasini D
    Mol Cell; 2014 Jan; 53(1):49-62. PubMed ID: 24289921
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2.
    Ngubo M; Moradi F; Ito CY; Stanford WL
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895228
    [TBL] [Abstract][Full Text] [Related]  

  • 65. EZH2 methyltransferase and H3K27 methylation in breast cancer.
    Yoo KH; Hennighausen L
    Int J Biol Sci; 2012; 8(1):59-65. PubMed ID: 22211105
    [TBL] [Abstract][Full Text] [Related]  

  • 66. EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition.
    Romero P; Richart L; Aflaki S; Petitalot A; Burton M; Michaud A; Masliah-Planchon J; Kuhnowski F; Le Cam S; Baliñas-Gavira C; Méaudre C; Luscan A; Hamza A; Legoix P; Vincent-Salomon A; Wassef M; Holoch D; Margueron R
    Nat Commun; 2024 Apr; 15(1):3452. PubMed ID: 38658543
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polycomb repressive complex 2 epigenomic signature defines age-associated hypermethylation and gene expression changes.
    Dozmorov MG
    Epigenetics; 2015; 10(6):484-95. PubMed ID: 25880792
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
    Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ
    Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Structural Perspective on Gene Repression by Polycomb Repressive Complex 2.
    Liu X
    Subcell Biochem; 2021; 96():519-562. PubMed ID: 33252743
    [TBL] [Abstract][Full Text] [Related]  

  • 70. DNA binding by PHF1 prolongs PRC2 residence time on chromatin and thereby promotes H3K27 methylation.
    Choi J; Bachmann AL; Tauscher K; Benda C; Fierz B; Müller J
    Nat Struct Mol Biol; 2017 Dec; 24(12):1039-1047. PubMed ID: 29058710
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PHF1 compartmentalizes PRC2 via phase separation.
    Lu G; Li P
    Biochem J; 2023 Nov; 480(22):1833-1844. PubMed ID: 37888776
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Histone H3.3K27M Mobilizes Multiple Cancer/Testis (CT) Antigens in Pediatric Glioma.
    Deng H; Zeng J; Zhang T; Gong L; Zhang H; Cheung E; Jones C; Li G
    Mol Cancer Res; 2018 Apr; 16(4):623-633. PubMed ID: 29453317
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Convergent evolution of chromatin modification by structurally distinct enzymes: comparative enzymology of histone H3 Lys²⁷ methylation by human polycomb repressive complex 2 and vSET.
    Swalm BM; Hallenbeck KK; Majer CR; Jin L; Scott MP; Moyer MP; Copeland RA; Wigle TJ
    Biochem J; 2013 Jul; 453(2):241-7. PubMed ID: 23679895
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In silico analysis of histone H3 gene expression during human brain development.
    Ren M; van Nocker S
    Int J Dev Biol; 2016; 60(4-6):167-73. PubMed ID: 27251074
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis.
    Guo P; Lim RC; Rajawasam K; Trinh T; Sun H; Zhang H
    Elife; 2024 Feb; 13():. PubMed ID: 38346162
    [TBL] [Abstract][Full Text] [Related]  

  • 76. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.
    McCabe MT; Ott HM; Ganji G; Korenchuk S; Thompson C; Van Aller GS; Liu Y; Graves AP; Della Pietra A; Diaz E; LaFrance LV; Mellinger M; Duquenne C; Tian X; Kruger RG; McHugh CF; Brandt M; Miller WH; Dhanak D; Verma SK; Tummino PJ; Creasy CL
    Nature; 2012 Dec; 492(7427):108-12. PubMed ID: 23051747
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.
    Lee W; Teckie S; Wiesner T; Ran L; Prieto Granada CN; Lin M; Zhu S; Cao Z; Liang Y; Sboner A; Tap WD; Fletcher JA; Huberman KH; Qin LX; Viale A; Singer S; Zheng D; Berger MF; Chen Y; Antonescu CR; Chi P
    Nat Genet; 2014 Nov; 46(11):1227-32. PubMed ID: 25240281
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss.
    Marchione DM; Lisby A; Viaene AN; Santi M; Nasrallah M; Wang LP; Williams EA; Larque AB; Chebib I; Garcia BA; Wojcik JB
    Mod Pathol; 2019 Oct; 32(10):1434-1446. PubMed ID: 31175328
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Paramecium Polycomb repressive complex 2 physically interacts with the small RNA-binding PIWI protein to repress transposable elements.
    Miró-Pina C; Charmant O; Kawaguchi T; Holoch D; Michaud A; Cohen I; Humbert A; Jaszczyszyn Y; Chevreux G; Del Maestro L; Ait-Si-Ali S; Arnaiz O; Margueron R; Duharcourt S
    Dev Cell; 2022 Apr; 57(8):1037-1052.e8. PubMed ID: 35429435
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Simultaneous disruption of PRC2 and enhancer function underlies histone H3.3-K27M oncogenic activity in human hindbrain neural stem cells.
    Brien GL; Bressan RB; Monger C; Gannon D; Lagan E; Doherty AM; Healy E; Neikes H; Fitzpatrick DJ; Deevy O; Grant V; Marqués-Torrejón MA; Alfazema N; Pollard SM; Bracken AP
    Nat Genet; 2021 Aug; 53(8):1221-1232. PubMed ID: 34294917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.